FDA Adverse Event Death Summary report: N

VITALITY

MDR report key: 2030398 · Received March 28, 2011

Report

Report Number
2124215-2011-05396
Event Type
Death
Date Received
March 28, 2011
Date of Event
February 24, 2011
Report Date
March 9, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Additional Manufacturer Narrative · 1

NO ADDITIONAL INFORMATION IS AVAILABLE AND THE DEVICE HAS NOT BEEN RETURNED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED AND/OR THE DEVICE IS RETURNED TO BOSTON SCIENTIFIC'S POST MARKET QUALITY ASSURANCE LABORATORY FOR ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT'S SON CONTACTED PATIENT SUPPORT AND REPORTED THAT THE PATIENT HAD EXPIRED IN (B)(6) 2011 FOLLOWING A CARDIAC ARREST. THE SON QUESTIONED WHETHER THE DEVICE FUNCTIONED APPROPRIATELY DURING THIS ADVERSE EVENT. THE SON INFORMED PATIENT SUPPORT THAT THE PATIENT'S MEDICAL HISTORY WAS REMARKABLE FOR MULTIPLE HEALTH ISSUES. THE PATIENT WAS ORIGINALLY ADMITTED FOR ABDOMINAL PAIN AND DIAGNOSTIC TESTING IDENTIFIED ARTERIES THAT WERE 50% AND 100% OCCLUDED. THE SON STATED THAT A STENT HAD BEEN INSERTED INTO THE 50% BLOCKED ARTERY, HOWEVER, DUE TO KIDNEY-RELATED ISSUES; A SPECIALIST WAS NOTIFIED TO EVALUATE THE OTHER OCCLUDED SITE. THE FAMILY MEMBER WAS NOT AWARE OF THE STENT MANUFACTURER OR THE LOCATION OF THE STENT. WHILE WAITING FOR FURTHER EVALUATION, THE PATIENT SUFFERED A CARDIAC ARREST THAT REQUIRED CARDIOPULMONARY RESUSCITATION (CPR) FOR FOUR MINUTES. THE FAMILY MEMBER REPORTED THAT DURING APPLICATION OF CPR, TWO RIBS WERE BROKEN. THE PATIENT WAS REVIVED BUT EVENTUALLY DIED OF ORGAN FAILURE. THE FAMILY MEMBER WAS UNAWARE IF THE DEVICE WOULD BE RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS BUT STATED THAT THE DEVICE WAS EXPLANTED PRIOR TO CREMATION. THE LOCAL REPRESENTATIVE WAS CONTACTED AND BOSTON SCIENTIFIC WAS NOTIFIED THAT THE PATIENT'S LAST IN-CLINIC FOLLOW-UP OCCURRED IN (B)(6) 2010. ALL DIAGNOSTIC MEASUREMENTS WERE WITHIN NORMAL RANGE AT THAT TIME. NO ANOMALIES WERE IDENTIFIED. THE LOCAL REPRESENTATIVE WAS NOT CONTACTED BY THE FUNERAL HOME FOLLOWING THIS PATIENT'S DEATH TO DEACTIVATE THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T135

Patients

Seq Age Sex Outcome Treatment
1 74 YR Death T135| 0157